4th Annual CKD Drug Development Summit

Published on 01/03/2022

1-3 March, 2022
Boston, USA

ENYO attended the 4th Chronic Kidney Disease Drug Development Summit, the only industry-led event dedicated to accelerating the frontier of preventative and regenerative therapies to meaningfully target kidney disease and enlighten opportunities for indication expansion into rare renal disorders. We presented a poster entitled “VONAFEXOR induces renal and hepatic improvements in NASH-LIVIFY trial results”.

https://ckd3-summit.com/

Read next in 'Events'

• J.P. Morgan week and WuXi Global Forum 2025 in San Francisco
• J.P. Morgan week et WuXi Global Forum 2025 à San Francisco
• 4th Rare & Genetic Kidney Disease Drug Development Summit
• 4th Rare & Genetic Kidney Disease Drug Development Summit
• MOSAIC - Global NASH Trialist Forum 2024